Skip to Main Content

Author Details

Paul M Krzyzanowski
Ontario Institute for Cancer Research
2005
30
17
PMIDPaper TitleJournal TitlePublished Year
35734926In-depth characterization of intratumoral heterogeneity in refractory B-cell non-Hodgkin lymphoma through the lens of a Research Autopsy Program.Haematologica2023
35694787Correction: GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer.Clin Cancer Res2022
33592074Prospective observational study and serosurvey of SARS-CoV-2 infection in asymptomatic healthcare workers at a Canadian tertiary care center.PLoS One2021
31435024Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing.Leukemia2020
31932696Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution.Nat Genet2020
32051610Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution.Nat Genet2020
32686686Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival.Nat Commun2020
32156747GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer.Clin Cancer Res2020
30686769Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases.Cancer Cell2019
31190949Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma.Clin Exp Gastroenterol2019
30837567Regional perturbation of gene transcription is associated with intrachromosomal rearrangements and gene fusion transcripts in high grade ovarian cancer.Sci Rep2019
31059681Detection of Circulating Tumor DNA in Plasma: A Potential Biomarker for Esophageal Adenocarcinoma.Ann Thorac Surg2019
30554450Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer.Head Neck2019
29288237Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial.Clin Cancer Res2018
29988082Prediction of acute myeloid leukaemia risk in healthy individuals.Nature2018
29483207Impact of Chemical-Induced Mutational Load Increase on Immune Checkpoint Therapy in Poorly Responsive Murine Tumors.Mol Cancer Ther2018
28273451Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High-Grade Serous Ovarian Cancer.Cell Rep2017
28253235Simple multiplexed PCR-based barcoding of DNA for ultrasensitive mutation detection by next-generation sequencing.Nat Protoc2017
26852132Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer.Breast Cancer Res2016
27060140Simple, multiplexed, PCR-based barcoding of DNA enables sensitive mutation detection in liquid biopsies using sequencing.Nucleic Acids Res2016
22555938Computational approaches to discovering noncoding RNA.Wiley Interdiscip Rev RNA2012
22901030CaPSID: a bioinformatics platform for computational pathogen sequence identification in human genomes and transcriptomes.BMC Bioinformatics2012
22585861Essential gene profiles in breast, pancreatic, and ovarian cancer cells.Cancer Discov2012
21698286Integration of expressed sequence tag data flanking predicted RNA secondary structures facilitates novel non-coding RNA discovery.PLoS One2011
22153076Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism.Cell2011
19284540Recent developments in StemBase: a tool to study gene expression in human and murine stem cells.BMC Res Notes2009
17875203Identification of novel stem cell markers using gap analysis of gene expression data.Genome Biol2007
18453254StemBase: a resource for the analysis of stem cell gene expression data.Methods Mol Biol2007
16331246Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Ciota-mediated attenuation of p38 MAP kinase signaling.Oncogene2006
15763554Study of stem cell function using microarray experiments.FEBS Lett2005
  • 1 - 30 of 30

Recommended Authors

Travers Ching
Adaptive Biotechnologies
Career Start Year 2014
Number of shared co-authors 0
Asha A Nair
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 1
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 2
Altuna Akalin
Berlin Institute for Medical Systems Biology
Career Start Year 2006
Number of shared co-authors 0
Raj Chari
The National Institutes of Health
Career Start Year 2006
Number of shared co-authors 2
Christopher A Maher
Washington University in St Louis
Career Start Year 2006
Number of shared co-authors 5
Han Liang
MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 8
Yongjun Zhao
Canada British Columbia Cancer Research Centre, University of British Columbia
Career Start Year 2005
Number of shared co-authors 5
Jason Walker
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2004
Number of shared co-authors 4
Steffen Durinck
Genentech Inc.
Career Start Year 2004
Number of shared co-authors 0
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 2
Pedro A F Galante
Hospital Sirio Libanes
Career Start Year 2003
Number of shared co-authors 0
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Pavel Sumazin
Baylor College of Medicine
Career Start Year 2003
Number of shared co-authors 1
Malachi Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 8
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 8
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 2
Peter J Park
Harvard Medical School
Career Start Year 2001
Number of shared co-authors 9
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 2
Andrew J Gentles
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 1
Shawn Levy
HudsonAlpha Institute for Biotechnology
Career Start Year 1999
Number of shared co-authors 0
Ru-Fang Yeh
Genentech Inc.
Career Start Year 1999
Number of shared co-authors 3
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 13
Sarah J Wheelan
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 0
Martin Hirst
University of British Columbia
Career Start Year 1998
Number of shared co-authors 7
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 16
Anamaria A Camargo
Hospital Sirio-Libanes
Career Start Year 1994
Number of shared co-authors 0
Samuel Aparicio
University of British Columbia
Career Start Year 1993
Number of shared co-authors 12
Sean M Grimmond
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 22
Jonathan R Pollack
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 4

Collaborators

Lincoln Stein
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 10
Miguel A Andrade-Navarro
Institute of Organismic and Molecular Evolution, Johannes Gutenberg University
Co-authored papers 7
Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Co-authored papers 7
John M S Bartlett
University of Edinburgh
Co-authored papers 7
Faiyaz Notta
2Ontario Institute for Cancer Research
Co-authored papers 7
Dianne Chadwick
University Health Network
Co-authored papers 6
Julie M Wilson
Ontario Institute for Cancer Research
Co-authored papers 6
Jessica K Miller
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 6
Gun Ho Jang
Ontario Institute for Cancer Research
Co-authored papers 6
Robert E Denroche
Ontario Institute for Cancer Research
Co-authored papers 6
John D McPherson
Ontario Institute for Cancer Research
Co-authored papers 5
Irina Kalatskaya
EMD Serono Research & Development Institute, Inc. (an affiliate of Merck KGaA)
Co-authored papers 4
Michelle Chan-Seng-Yue
Princess Margaret Cancer Centre
Co-authored papers 4
Ashton A Connor
Houston Methodist Hospital
Co-authored papers 4
Lawrence E Heisler
Ontario Institute for Cancer Research
Co-authored papers 3
Danielle Pasternack
Nicklaus Children's Hospital
Co-authored papers 3
Lee Timms
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 3
Christopher J Porter
Ottawa Hospital Research Institute
Co-authored papers 3
Mathieu Lemire
The Hospital for Sick Children
Co-authored papers 3
Gareth A Palidwor
Ottawa Hospital Research Institute
Co-authored papers 3
Peter J Campbell
Wellcome Sanger Institute
Co-authored papers 3
Mehdi Masoomian
University Health Network
Co-authored papers 2
Xuemei Luo
Ganzhou Municipal Health Commission
Co-authored papers 2
Rama Khokha
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Janessa Laskin
Co-authored papers 2
Philip C Zuzarte
Ontario Institute for Cancer Research
Co-authored papers 2
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Marco A Marra
University of British Columbia
Co-authored papers 2
Steven J M Jones
University of British Columbia
Co-authored papers 2
Kevin R Brown
College Street, University of Toronto
Co-authored papers 2
Release 1.2